Furthermore, antibodies against CL have been identified in patients with lupus, inflammatory bowel disease, and Antiphospholipid Syndrome [55, 56, 58], diseases that are thought to be linked to TLR4 [59–62]. Here, TLR4 is linked to antiphospholipid syndrome.